Board approves name change, new directors, and expanded business objects

The board approved regularizing Sachin Manseta as Non-Executive Independent Director and Chirag Dedhia as Non-Executive Non-Independent Director, effective July 22, 2026 for 5 years. It also approved changing the company name from Sattva Sukun Lifecare to one of Tavexia, Trumaxa, Trustarex, or Tradamex Lifecare, pending approvals. The MOA object clause was expanded to add chemicals, pharmaceutical APIs, biotechnology, and CRO/CDMO services. An EGM was called for shareholder approvals.